MTOR independent regulation of macroautophagy by Leucine Rich Repeat Kinase 2 via Beclin-1

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Manzoni, Claudia ^a,b   Mamais, Adamantios ^c   Roosen, Dorien A ^b,c   Dihanich, Sybille ^b   Soutar, Marc P M ^b   Plun Favreau, Helene ^d   Bandopadhyay, Rina ^b   Hardy, John ^b   Tooze, Sharon A ^e   Cookson, Mark R ^c   Lewis, Patrick A ^a,b  

^a UNIVERSITY OF READING   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c NATIONAL INSTITUTE ON AGING   (United States)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

^e THE FRANCIS CRICK INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BECLIN 1; LEUCINE RICH REPEAT KINASE 2; MAP1LC3A PROTEIN, HUMAN; MICROTUBULE ASSOCIATED PROTEIN; PROTEIN KINASE INHIBITOR; SERINE THREONINE PROTEIN KINASE ULK1; TARGET OF RAPAMYCIN KINASE;

ANIMAL; ANTAGONISTS AND INHIBITORS; ASTROCYTE; AUTOPHAGY; CELL CULTURE; CELL LINE; CYTOLOGY; DRUG EFFECTS; GENETICS; HUMAN; METABOLISM; MOUSE; MUTATION; PARKINSON DISEASE; PATHOLOGY; PHYSIOLOGY;

ANIMALS; ASTROCYTES; AUTOPHAGY; AUTOPHAGY-RELATED PROTEIN-1 HOMOLOG; BECLIN-1; CELL LINE; CELLS, CULTURED; HUMANS; LEUCINE-RICH REPEAT SERINE-THREONINE PROTEIN KINASE-2; MICE; MICROTUBULE-ASSOCIATED PROTEINS; MUTATION; PARKINSON DISEASE; PROTEIN KINASE INHIBITORS; TOR SERINE-THREONINE KINASES;

EID: 84991112144     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep35106     Document Type: Article

References (61)

1. Hernandez, D. G., Reed, X., Singleton, A. B. Genetics in Parkinson disease: Mendelian versus non-Mendelian inheritance. J Neurochem, doi: 10. 1111/jnc. 13593 (2016).
2. Paisan-Ruiz, C. et al. Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease. Neuron 44, 595-600, doi: 10. 1016/j. neuron. 2004. 10. 023 (2004).
3. Singleton, A. B., Farrer, M. J., Bonifati, V. The genetics of Parkinson's disease: progress and therapeutic implications. Mov Disord 28, 14-23, doi: 10. 1002/mds. 25249 (2013).
4. Zimprich, A. et al. Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology. Neuron 44, 601-607, doi: 10. 1016/j. neuron. 2004. 11. 005 (2004).
5. Nalls, M. A. et al. Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson's disease. Nat Genet 46, 989-993, doi: 10. 1038/ng. 3043 (2014).
6. Jostins, L. et al. Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature 491, 119-124, doi: 10. 1038/nature11582 (2012).
7. Fava, V. M. et al. A Missense LRRK2 Variant Is a Risk Factor for Excessive Inflammatory Responses in Leprosy. Plos Negl Trop Dis 10, e0004412, doi: 10. 1371/journal. pntd. 0004412 (2016).
8. Zhang, F. R. et al. Genomewide association study of leprosy. N Engl J Med 361, 2609-2618, doi: 10. 1056/NEJMoa0903753 (2009).
9. Inzelberg, R. et al. The LRRK2 G2019S mutation is associated with Parkinson disease and concomitant non-skin cancers. Neurology 78, 781-786, doi: 10. 1212/WNL. 0b013e318249f673 (2012).
10. Agalliu, I. et al. Higher frequency of certain cancers in LRRK2 G2019S mutation carriers with Parkinson disease: a pooled analysis. JAMA Neurol 72, 58-65, doi: 10. 1001/jamaneurol. 2014. 1973 (2015).
11. Biosa, A. et al. GTPase activity regulates kinase activity and cellular phenotypes of Parkinson's disease-associated LRRK2. Hum Mol Genet 22, 1140-1156, doi: 10. 1093/hmg/dds522 (2013).
12. Webber, P. J. et al. Autophosphorylation in the leucine-rich repeat kinase 2 (LRRK2) GTPase domain modifies kinase and GTPbinding activities. J Mol Biol 412, 94-110, doi: 10. 1016/j. jmb. 2011. 07. 033 (2011).
13. Wirth, M., Joachim, J., Tooze, S. A. Autophagosome formation-the role of ULK1 and Beclin1-PI3KC3 complexes in setting the stage. Semin Cancer Biol 23, 301-309, doi: 10. 1016/j. semcancer. 2013. 05. 007 (2013).
14. Plowey, E. D., Cherra, S. J. 3rd., Liu, Y. J., Chu, C. T. Role of autophagy in G2019S-LRRK2-associated neurite shortening in differentiated SH-SY5Y cells. J Neurochem 105, 1048-1056, doi: 10. 1111/j. 1471-4159. 2008. 05217. x (2008).
15. Alegre-Abarrategui, J. et al. LRRK2 regulates autophagic activity and localizes to specific membrane microdomains in a novel human genomic reporter cellular model. Hum Mol Genet 18, 4022-4034, doi: 10. 1093/hmg/ddp346 (2009).
16. Schapansky, J., Nardozzi, J. D., Felizia, F., LaVoie, M. J. Membrane recruitment of endogenous LRRK2 precedes its potent regulation of autophagy. Hum Mol Genet 23, 4201-4214, doi: 10. 1093/hmg/ddu138 (2014).
17. Gomez-Suaga, P. et al. Leucine-rich repeat kinase 2 regulates autophagy through a calcium-dependent pathway involving NAADP. Hum Mol Genet 21, 511-525, doi: 10. 1093/hmg/ddr481 (2012).
18. Manzoni, C. et al. Inhibition of LRRK2 kinase activity stimulates macroautophagy. Biochim Biophys Acta 1833, 2900-2910, doi: 10. 1016/j. bbamcr. 2013. 07. 020 (2013).
19. Saez-Atienzar, S. et al. The LRRK2 inhibitor GSK2578215A induces protective autophagy in SH-SY5Y cells: involvement of Drp-1-mediated mitochondrial fission and mitochondrial-derived ROS signaling. Cell Death Dis 5, e1368, doi: 10. 1038/cddis. 2014. 320 (2014).
20. Bravo-San Pedro, J. M. et al. The LRRK2 G2019S mutant exacerbates basal autophagy through activation of the MEK/ERK pathway. Cell Mol Life Sci 70, 121-136, doi: 10. 1007/s00018-012-1061-y (2013).
21. Manzoni, C. et al. Pathogenic Parkinson's disease mutations across the functional domains of LRRK2 alter the autophagic/lysosomal response to starvation. Biochem Biophys Res Commun 441, 862-866, doi: 10. 1016/j. bbrc. 2013. 10. 159 (2013).
22. Sanchez-Danes, A. et al. Disease-specific phenotypes in dopamine neurons from human iPS-based models of genetic and sporadic Parkinson's disease. EMBO Mol Med 4, 380-395, doi: 10. 1002/emmm. 201200215 (2012).
23. Tong, Y. et al. Loss of leucine-rich repeat kinase 2 causes age-dependent bi-phasic alterations of the autophagy pathway. Mol Neurodegener 7, 2, doi: 10. 1186/1750-1326-7-2 (2012).
24. Orenstein, S. J. et al. Interplay of LRRK2 with chaperone-mediated autophagy. Nat Neurosci 16, 394-406, doi: 10. 1038/nn. 3350 (2013).
25. Arranz, A. M. et al. LRRK2 functions in synaptic vesicle endocytosis through a kinase-dependent mechanism. J Cell Sci 128, 541-552, doi: 10. 1242/jcs. 158196 (2015).
26. Belluzzi, E. et al. LRRK2 phosphorylates pre-synaptic N-ethylmaleimide sensitive fusion (NSF) protein enhancing its ATPase activity and SNARE complex disassembling rate. Mol Neurodegener 11, 1, doi: 10. 1186/s13024-015-0066-z (2016).
27. Chia, R. et al. Phosphorylation of LRRK2 by casein kinase 1alpha regulates trans-Golgi clustering via differential interaction with ARHGEF7. Nat Commun 5, 5827, doi: 10. 1038/ncomms6827 (2014).
28. Matta, S. et al. LRRK2 controls an EndoA phosphorylation cycle in synaptic endocytosis. Neuron 75, 1008-1021, doi: 10. 1016/j. neuron. 2012. 08. 022 (2012).
29. Xilouri, M., Brekk, O. R., Stefanis, L. Autophagy and Alpha-Synuclein: Relevance to Parkinson's Disease and Related Synucleopathies. Mov Disord 31, 178-192, doi: 10. 1002/mds. 26477 (2016).
30. Henry, A. G. et al. Pathogenic LRRK2 mutations, through increased kinase activity, produce enlarged lysosomes with reduced degradative capacity and increase ATP13A2 expression. Hum Mol Genet 24, 6013-6028, doi: 10. 1093/hmg/ddv314 (2015).
31. Moehle, M. S. et al. LRRK2 inhibition attenuates microglial inflammatory responses. J Neurosci 32, 1602-1611, doi: 10. 1523/JNEUROSCI. 5601-11. 2012 (2012).
32. Deng, X. et al. Characterization of a selective inhibitor of the Parkinson's disease kinase LRRK2. Nat Chem Biol 7, 203-205, doi: 10. 1038/nchembio. 538 (2011).
33. Reith, A. D. et al. GSK2578215A; a potent and highly selective 2-arylmethyloxy-5-substitutent-N-arylbenzamide LRRK2 kinase inhibitor. Bioorg Med Chem Lett 22, 5625-5629, doi: 10. 1016/j. bmcl. 2012. 06. 104 (2012).
34. Klionsky, D. J. et al. Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition). Autophagy 12, 1-222, doi: 10. 1080/15548627. 2015. 1100356 (2016).
35. Mauvezin, C., Nagy, P., Juhasz, G., Neufeld, T. P. Autophagosome-lysosome fusion is independent of V-ATPase-mediated acidification. Nat Commun 6, 7007, doi: 10. 1038/ncomms8007 (2015).
36. Tooze, S. A. et al. Assessing mammalian autophagy. Methods Mol Biol 1270, 155-165, doi: 10. 1007/978-1-4939-2309-0-12 (2015).
37. Papinski, D., Kraft, C. Regulation of Autophagy By Signaling Through the Atg1/ULK1 Complex. J Mol Biol, doi: 10. 1016/j. jmb. 2016. 03. 030 (2016).
38. Johnson, C. W., Melia, T. J., Yamamoto, A. Modulating macroautophagy: a neuronal perspective. Future Med Chem 4, 1715-1731, doi: 10. 4155/fmc. 12. 112 (2012).
39. Lewis, P. A., Manzoni, C. LRRK2 and human disease: a complicated question or a question of complexes? Sci Signal 5, 2, doi: 10. 1126/scisignal. 2002680 (2012).
40. Ktistakis, N. T., Tooze, S. A. Digesting the Expanding Mechanisms of Autophagy. Trends Cell Biol, doi: 10. 1016/j. tcb. 2016. 03. 006 (2016).
41. Alers, S., Loffler, A. S., Wesselborg, S., Stork, B. Role of AMPK-mTOR-Ulk1/2 in the regulation of autophagy: cross talk, shortcuts, and feedbacks. Mol Cell Biol 32, 2-11, doi: 10. 1128/MCB. 06159-11 (2012).
42. McAlpine, F., Williamson, L. E., Tooze, S. A., Chan, E. Y. Regulation of nutrient-sensitive autophagy by uncoordinated 51-like kinases 1 and 2. Autophagy 9, 361-373, doi: 10. 4161/auto. 23066 (2013).
43. Codogno, P., Mehrpour, M., Proikas-Cezanne, T. Canonical and non-canonical autophagy: variations on a common theme of selfeating? Nat Rev Mol Cell Biol 13, 7-12, doi: 10. 1038/nrm3249 (2012).
44. Mauthe, M. et al. Resveratrol-mediated autophagy requires WIPI-1-regulated LC3 lipidation in the absence of induced phagophore formation. Autophagy 7, 1448-1461 (2011).
45. Wang, J. et al. A non-canonical MEK/ERK signaling pathway regulates autophagy via regulating Beclin 1. J Biol Chem 284, 21412-21424, doi: 10. 1074/jbc. M109. 026013 (2009).
46. Cheong, H., Lindsten, T., Wu, J., Lu, C., Thompson, C. B. Ammonia-induced autophagy is independent of ULK1/ULK2 kinases. Proc Natl Acad Sci USA 108, 11121-11126, doi: 10. 1073/pnas. 1107969108 (2011).
47. Alers, S. et al. Atg13 and FIP200 act independently of Ulk1 and Ulk2 in autophagy induction. Autophagy 7, 1423-1433 (2011).
48. Sarkar, S. et al. Small molecules enhance autophagy and reduce toxicity in Huntington's disease models. Nat Chem Biol 3, 331-338, doi: 10. 1038/nchembio883 (2007).
49. Su, Y. C., Guo, X., Qi, X. Threonine 56 phosphorylation of Bcl-2 is required for LRRK2 G2019S-induced mitochondrial depolarization and autophagy. Biochim Biophys Acta 1852, 12-21, doi: 10. 1016/j. bbadis. 2014. 11. 009 (2015).
50. Decuypere, J. P., Parys, J. B., Bultynck, G. Regulation of the autophagic bcl-2/beclin 1 interaction. Cells 1, 284-312, doi: 10. 3390/cells1030284 (2012).
51. Wei, Y. et al. The stress-responsive kinases MAPKAPK2/MAPKAPK3 activate starvation-induced autophagy through Beclin 1 phosphorylation. Elife 4, doi: 10. 7554/eLife. 05289 (2015).
52. Gloeckner, C. J., Schumacher, A., Boldt, K., Ueffing, M. The Parkinson disease-associated protein kinase LRRK2 exhibits MAPKKK activity and phosphorylates MKK3/6 and MKK4/7, in vitro. J Neurochem 109, 959-968, doi: 10. 1111/j. 1471-4159. 2009. 06024. x (2009).
53. Funderburk, S. F., Wang, Q. J., Yue, Z. The Beclin 1-VPS34 complex-at the crossroads of autophagy and beyond. Trends Cell Biol 20, 355-362, doi: 10. 1016/j. tcb. 2010. 03. 002 (2010).
54. Matsunaga, K. et al. Two Beclin 1-binding proteins, Atg14L and Rubicon, reciprocally regulate autophagy at different stages. Nat Cell Biol 11, 385-396, doi: 10. 1038/ncb1846 (2009).
55. Zhong, Y. et al. Distinct regulation of autophagic activity by Atg14L and Rubicon associated with Beclin 1-phosphatidylinositol-3-kinase complex. Nat Cell Biol 11, 468-476, doi: 10. 1038/ncb1854 (2009).
56. Zalckvar, E., Berissi, H., Eisenstein, M., Kimchi, A. Phosphorylation of Beclin 1 by DAP-kinase promotes autophagy by weakening its interactions with Bcl-2 and Bcl-XL. Autophagy 5, 720-722 (2009).
57. Zalckvar, E. et al. DAP-kinase-mediated phosphorylation on the BH3 domain of beclin 1 promotes dissociation of beclin 1 from Bcl-XL and induction of autophagy. EMBO Rep 10, 285-292, doi: 10. 1038/embor. 2008. 246 (2009).
58. Liu, Z., Mobley, J. A., DeLucas, L. J., Kahn, R. A., West, A. B. LRRK2 autophosphorylation enhances its GTPase activity. FASEB J 30, 336-347, doi: 10. 1096/fj. 15-277095 (2016).
59. Wallings, R., Manzoni, C., Bandopadhyay, R. Cellular processes associated with LRRK2 function and dysfunction. FEBS J 282, 2806-2826, doi: 10. 1111/febs. 13305 (2015).
60. Manzoni, C., Denny, P., Lovering, R. C., Lewis, P. A. Computational analysis of the LRRK2 interactome. PeerJ 3, e778, doi: 10. 7717/peerj. 778 (2015).
61. Schildge, S., Bohrer, C., Beck, K., Schachtrup, C. Isolation and culture of mouse cortical astrocytes. J Vis Exp, doi: 10. 3791/50079 (2013).